These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 2347954

  • 1. Clinical pharmacology of dilevalol (i.v.). Influence of hepatic and renal functions on the disposition of dilevalol and atenolol in hypertensive subjects.
    Kotegawa T, Fujimura A, Ebihara A.
    J Clin Pharmacol; 1990 May; 30(5):404-8. PubMed ID: 2347954
    [Abstract] [Full Text] [Related]

  • 2. Clinical pharmacology of dilevalol (III). A pharmacokinetic study of dilevalol in elderly subjects with essential hypertension.
    Fujimura A, Sugimoto K, Kumagai Y, Nakashima H, Ebihara A.
    J Clin Pharmacol; 1989 Nov; 29(11):1008-12. PubMed ID: 2574727
    [Abstract] [Full Text] [Related]

  • 3. Clinical pharmacology of dilevalol (I). Comparison of the pharmacokinetic and pharmacodynamic properties of dilevalol and labetalol after a single oral administration in healthy subjects.
    Fujimura A, Ohashi K, Tsuru M, Ebihara A, Kondo K.
    J Clin Pharmacol; 1989 Jul; 29(7):635-42. PubMed ID: 2668352
    [Abstract] [Full Text] [Related]

  • 4. Randomised, double-blind, three-way cross-over study of dilevalol 200 and 400 mg and atenolol 100 mg once-daily in patients with chronic stable angina pectoris.
    Bowles MJ, Smith L, Glover DR.
    J Hum Hypertens; 1990 Jun; 4 Suppl 2():85-90. PubMed ID: 2196372
    [Abstract] [Full Text] [Related]

  • 5. Renal function effects of dilevalol, a nonselective beta-adrenergic blocking drug with beta-2 agonist activity.
    Cook ME, Wallin JD, Clifton GG, Poland M.
    Clin Pharmacol Ther; 1988 Apr; 43(4):393-9. PubMed ID: 3356083
    [Abstract] [Full Text] [Related]

  • 6. Effects of dilevalol, metoprolol and atenolol on left ventricular mass and function in nonelderly and elderly hypertensive patients.
    Frishman WH, Glasser SP, Strom JA, Schoenberger JA, Liebson P, Poland MP.
    Am J Cardiol; 1989 Jun 05; 63(19):69I-74I. PubMed ID: 2567114
    [Abstract] [Full Text] [Related]

  • 7. Clinical pharmacology of dilevalol (II). The pharmacokinetic, pharmacodynamic, and tolerance studies of dilevalol during repeated administration in healthy subjects.
    Fujimura A, Ohashi K, Tsuru M, Ebihara A, Kondo K.
    J Clin Pharmacol; 1989 Jul 05; 29(7):643-9. PubMed ID: 2760257
    [Abstract] [Full Text] [Related]

  • 8. The pharmacokinetics of dilevalol in renal impairment.
    Kelly JG, Laher MS, Donohue J, Doyle GD.
    J Hum Hypertens; 1990 Jun 05; 4 Suppl 2():59-62. PubMed ID: 2370645
    [Abstract] [Full Text] [Related]

  • 9. Comparative effects of dilevalol and atenolol on lung function and airway response to methacholine in hypertensive subjects.
    Boulet LP, Lacourcière Y, Milot J, Lampron N.
    Br J Clin Pharmacol; 1990 Jun 05; 29(6):725-31. PubMed ID: 2198911
    [Abstract] [Full Text] [Related]

  • 10. The renal function and blood pressure effects of dilevalol in the normotensive and hypertensive elderly.
    Clifton GG, Cook ME, Poland M, Wallin JD.
    J Clin Pharmacol; 1989 Jul 05; 29(7):603-8. PubMed ID: 2760254
    [Abstract] [Full Text] [Related]

  • 11. Clinical pharmacokinetics and kinetic-dynamic relationships of dilevalol and labetalol.
    Donnelly R, Macphee GJ.
    Clin Pharmacokinet; 1991 Aug 05; 21(2):95-109. PubMed ID: 1884570
    [Abstract] [Full Text] [Related]

  • 12. Secretion of dilevalol in breast milk.
    Radwanski E, Nagabhushan N, Affrime MB, Perentesis G, Symchowicz S, Patrick JE.
    J Clin Pharmacol; 1988 May 05; 28(5):448-53. PubMed ID: 2899094
    [Abstract] [Full Text] [Related]

  • 13. Dilevalol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in hypertension.
    Chrisp P, Goa KL.
    Drugs; 1990 Feb 05; 39(2):234-63. PubMed ID: 2184002
    [Abstract] [Full Text] [Related]

  • 14. Pharmacokinetics of dilevalol and its conjugates in man. Assay method for plasma, blood, urine and bile samples and preliminary pharmacokinetic studies.
    Neubeck M, Becker C, Henke D, Rösch W, Spahn-Langguth H, Mutschler E.
    Arzneimittelforschung; 1993 Sep 05; 43(9):953-7. PubMed ID: 8240457
    [Abstract] [Full Text] [Related]

  • 15. Pharmacokinetics and pharmacodynamics of dilevalol.
    Tenero DM, Bottorff MB, Given BD, Kramer WG, Affrime MB, Patrick JE, Lalonde RL.
    Clin Pharmacol Ther; 1989 Dec 05; 46(6):648-56. PubMed ID: 2598569
    [Abstract] [Full Text] [Related]

  • 16. Pharmacokinetics of dilevalol in normotensive and hypertensive volunteers.
    Kramer WG, Perentesis G, Affrime MB, Patrick JE.
    Am J Cardiol; 1989 Jun 05; 63(19):7I-11I. PubMed ID: 2729127
    [Abstract] [Full Text] [Related]

  • 17. Antihypertensive effect of dilevalol is directly related to dose and plasma concentrations.
    Given BD, Perentesis G, Christopher JD, Herron J, Patrick JE, Kramer WG, Affrime MB.
    Am J Cardiol; 1989 Jun 05; 63(19):12I-16I. PubMed ID: 2729123
    [Abstract] [Full Text] [Related]

  • 18. Comparison of central and peripheral haemodynamic effects of dilevalol and atenolol in essential hypertension.
    Tham TC, Silke B, Taylor SH.
    J Hum Hypertens; 1990 Jun 05; 4 Suppl 2():77-83. PubMed ID: 2370647
    [Abstract] [Full Text] [Related]

  • 19. Overview of clinical trials of dilevalol in essential hypertension.
    Glover DR, Tarbit WJ.
    J Hum Hypertens; 1990 Jun 05; 4 Suppl 2():49-53. PubMed ID: 2142508
    [Abstract] [Full Text] [Related]

  • 20. Differences of chronopharmacokinetic profiles between propranolol and atenolol in hypertensive subjects.
    Shiga T, Fujimura A, Tateishi T, Ohashi K, Ebihara A.
    J Clin Pharmacol; 1993 Aug 05; 33(8):756-61. PubMed ID: 8408738
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.